findmyKOL
Clinical trialNCT06544265RecruitingPhase 1Interventional

SynKIR-310 for Relapsed/Refractory B-NHL

SponsorVerismo TherapeuticsEnrollment36Aggressive B-Cell Non-Hodgkin LymphomaB Cell LymphomaDLBCLDLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic InflammationDLBCL - Diffuse Large B Cell LymphomaDiffuse Large B Cell Lymphoma+20 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Colorado Blood Cancer Institute, Part of Sarah Cannon Cancer Institute

    Denver, Colorado, United States

    Michael T. Tees, MD
    Recruiting
  • Winship Cancer Institute of Emory University

    Atlanta, Georgia, United States

    Edmund Waller, MD, PhD
    Recruiting
  • the University of Kansas Cancer Center

    Fairway, Kansas, United States

    Joseph McGuirk, DO
    Recruiting
  • Rutgers Cancer Institute

    New Brunswick, New Jersey, United States

    Matthew Matasar, MD
    Recruiting
  • Abramson Cancer Center of the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Stephen Schuster, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Nov 2024
Primary completion
30 Sept 2028
Completion
31 Dec 2028
Last update posted
14 Apr 2026
Registered enrollment
36
Registry id
NCT06544265
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.